COVID trials improved diversity recruiting, says Moderna Top Scientist Ruchika Sharma3 Dec 2022 4:00 PM ISTNew York: Moderna Inc's top scientist has said that the vaccine maker has learned how to better recruit from diverse populations for its clinical...
Roche to stop all Gantenerumab studies in early Alzheimer's disease Ruchika Sharma2 Dec 2022 2:30 PM ISTRoche is still testing a different formulation of gantenerumab called trontinemab, designed to ferry the drug across the blood brain barrier -...
Scientific approach followed in Covaxin approval: Govt rebuts all allegations on Bharat Biotech Covaxin hurried approval Ruchika Sharma17 Nov 2022 3:30 PM ISTNew Delhi: There have been media reports claiming that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine – Covaxin, "had to skip certain...
Medical Bulletin 9/November/2022 Dr Rashi Prakash9 Nov 2022 4:00 PM ISTHere are the top medical news for the day:New one-stop guideline for cardiovascular health in CanadaMedications to follow to treat cardiovascular...
Clinical trial finds novel therapy markedly reduced lipoprotein(a) levels in people with cardiovascular disease Dr Rashi Prakash9 Nov 2022 9:15 AM ISTLipoprotein(a) is a special type of bad cholesterol that is believed to contribute to heart disease, but there are no approved pharmacological...
First-ever clinical trial of lab-grown blood cell transfusion aimed at combating rare disorders in UK Kajal Rajput8 Nov 2022 2:00 PM ISTThe team, including researchers from the University of Cambridge in the UK, said the blood cells were grown from stem cells from donors. The red cells...
COMP360 psilocybin reduces depression symptoms: Phase 2b trial findings Isra Zaman4 Nov 2022 9:00 AM IST Approximately 100 million people in the world suffer with treatment-resistant depression, which means they have not responded to at least two...
Repotrectinib could be effective for treating ROS1 positive NSCLC: TRIDENT-1 trial Isra Zaman31 Oct 2022 9:30 AM ISTRepotrectinib has been designed to help patients with NSCLC that have a genetic rearrangement in their tumour cells called ROS1positive that can...
CDSCO panel approves Intas pharma to continue Tofacitinib Ointment 2% CT Study Dr. Divya Colin29 Oct 2022 5:15 PM ISTNew Delhi: Citing that drug maker, Intas Pharma should report in case of any Serious Adverse Events (SAEs) related to the Phase III clinical trial of...
Targeted lung cancer drug repotrectinib shows promise in TRIDENT-1 trial Dr. Kamal Kant Kohli29 Oct 2022 4:45 AM ISTResearchers have found in TRIDENT-1 trial that targeted drug repotrectinib could help treat patients with a certain type of non-small cell lung...
Medical Bulletin 28/October/2022 Isra Zaman28 Oct 2022 5:00 PM ISTHere are the top medical news for the day:Specific alterations in the BRAF gene found that may affect treatment and survival response in adult brain...
Olaparib and adavosertib, work best when given sequentially in patients with advanced tumours: results from Phase Ib STAR clinical trial Isra Zaman28 Oct 2022 10:00 AM ISTPresenting results from the phase Ib STAR clinical trial to the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in...
